Back to Search
Start Over
Flat is the new up: after a sharp downturn, consumer ad outlays have stabilized. Advertisers are spending again, but with budgets under pressure, they're seeking deals, and amid thinning pipelines, they're supporting mature blockbusters later in their lifecycles. Matthew Arnold reports on the trends
- Source :
- Medical Marketing & Media. April, 2010, Vol. 45 Issue 4, p38, 5 p.
- Publication Year :
- 2010
-
Abstract
- Just a few years ago, the news that pharma ad spend was up a mere 2% would have been greeted with horror in adland. But that was before--before a dizzying [...]
- Subjects :
- Merck & Company Inc. -- Advertising
Amgen Inc. -- Advertising
Warner Chilcott Inc. -- Advertising
Pfizer Inc. -- Advertising
Boehringer Ingelheim GmbH -- Advertising
AstraZeneca PLC -- Advertising
Eli Lilly and Co. -- Advertising
Abbott Laboratories (Abbott Park, Illinois) -- Advertising
Sanofi-Aventis S.A. -- Advertising
Bayer AG -- Advertising
Novartis AG -- Advertising
Otsuka Pharmaceutical Company Ltd. -- Advertising
GlaxoSmithKline PLC -- Advertising
Allergan Inc. -- Advertising
Roche Holding AG -- Advertising
Pharmaceutical industry
Business
Health care industry
Abilify (Medication) -- Advertising
Pristiq (Medication) -- Advertising
Yaz (Contraceptive) -- Advertising
Viagra (Medication) -- Advertising
Symbicort (Medication) -- Advertising
Plavix (Medication) -- Advertising
Flomax (Medication) -- Advertising
Lipitor (Medication) -- Advertising
Cymbalta (Medication) -- Advertising
Cialis (Medication) -- Advertising
Advair Diskus (Medication) -- Advertising
Lyrica (Medication) -- Advertising
Ambien CR (Medication) -- Advertising
Crestor (Medication) -- Advertising
Chantix (Medication) -- Advertising
Subjects
Details
- Language :
- English
- ISSN :
- 00257354
- Volume :
- 45
- Issue :
- 4
- Database :
- Gale General OneFile
- Journal :
- Medical Marketing & Media
- Publication Type :
- Periodical
- Accession number :
- edsgcl.224994025